Profiel
Iraj Ali is Chief Executive Officer & Director at Achilles Therapeutics Plc since 2018.
Former roles include Chief Executive Officer & Director at Achilles Therapeutics UK Ltd. from 2018 to 2025, Director at NightstaRx Ltd., Director & Investment Partner at Blue Earth Diagnostics Ltd. from 2014 to 2018, Director & Investment Partner at Nightstar Therapeutics Ltd. from 2013 to 2015, Managing Partner at Syncona Ltd. from 2016 to 2018, Partner at Syncona Partners LLP, and Associate & Principal at McKinsey & Company Holdings Ltd. from 2006 to 2012.
Education includes a doctorate from the University of Cambridge and an undergraduate degree from The University of Reading.
Actieve functies van Iraj Ali
| Bedrijven | Functie | Begin |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Algemeen Directeur | 01-01-2018 |
Eerdere bekende functies van Iraj Ali
| Bedrijven | Functie | Einde |
|---|---|---|
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Algemeen Directeur | 01-03-2025 |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Directeur/Bestuurslid | 01-12-2018 |
| SYNCONA LIMITED | Corporate Officer/Principal | 01-12-2018 |
| NIGHTSTAR THERAPEUTICS PLC | Directeur/Bestuurslid | 01-11-2015 |
McKinsey & Company Holdings Ltd.
McKinsey & Company Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | 01-09-2012 |
Opleiding van Iraj Ali
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Syncona Ltd.
Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Reading
The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Health Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Nightstar Therapeutics Ltd.
Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
McKinsey & Company Holdings Ltd.
McKinsey & Company Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Achilles Therapeutics Plc
Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
















